181 related articles for article (PubMed ID: 9280283)
21. An exon-skipping mutation in the btk gene of a patient with X-linked agammaglobulinemia and isolated growth hormone deficiency.
Duriez B; Duquesnoy P; Dastot F; Bougnères P; Amselem S; Goossens M
FEBS Lett; 1994 Jun; 346(2-3):165-70. PubMed ID: 8013627
[TBL] [Abstract][Full Text] [Related]
22. Structural basis for X-linked agammaglobulinemia (XLA): mutations at interacting Btk residues R562, W563, and A582.
Maniar HS; Vihinen M; Webster AD; Nilsson L; Smith CI
Clin Immunol Immunopathol; 1995 Sep; 76(3 Pt 2):S198-202. PubMed ID: 7554468
[TBL] [Abstract][Full Text] [Related]
23. Analysis of Btk mutations in patients with X-linked agammaglobulinaemia (XLA) and determination of carrier status in normal female relatives: a nationwide study of Btk deficiency in Greece.
Speletas M; Kanariou M; Kanakoudi-Tsakalidou F; Papadopoulou-Alataki E; Arvanitidis K; Pardali E; Constantopoulos A; Kartalis G; Vihinen M; Sideras P; Ritis K
Scand J Immunol; 2001 Sep; 54(3):321-7. PubMed ID: 11555397
[TBL] [Abstract][Full Text] [Related]
24. Identification of Btk mutations in 20 unrelated patients with X-linked agammaglobulinaemia (XLA).
Jin H; Webster AD; Vihinen M; Sideras P; Vorechovsky I; Hammarstróm L; Bernatowska-Matuszkiewicz E; Smith CI; Bobrow M; Vetrie D
Hum Mol Genet; 1995 Apr; 4(4):693-700. PubMed ID: 7633420
[TBL] [Abstract][Full Text] [Related]
25. Screening of genomic DNA to identify mutations in the gene for Bruton's tyrosine kinase.
Conley ME; Fitch-Hilgenberg ME; Cleveland JL; Parolini O; Rohrer J
Hum Mol Genet; 1994 Oct; 3(10):1751-6. PubMed ID: 7849697
[TBL] [Abstract][Full Text] [Related]
26. Colocalization of X-linked agammaglobulinemia and X-linked immunodeficiency genes.
Thomas JD; Sideras P; Smith CI; Vorechovský I; Chapman V; Paul WE
Science; 1993 Jul; 261(5119):355-8. PubMed ID: 8332900
[TBL] [Abstract][Full Text] [Related]
27. Pleckstrin homology domains of tec family protein kinases.
Okoh MP; Vihinen M
Biochem Biophys Res Commun; 1999 Nov; 265(1):151-7. PubMed ID: 10548506
[TBL] [Abstract][Full Text] [Related]
28. Maternal germinal mosaicism of X-linked agammaglobulinemia.
Sakamoto M; Kanegane H; Fujii H; Tsukada S; Miyawaki T; Shinomiya N
Am J Med Genet; 2001 Mar; 99(3):234-7. PubMed ID: 11241495
[TBL] [Abstract][Full Text] [Related]
29. Solution structure of the human BTK SH3 domain complexed with a proline-rich peptide from p120cbl.
Tzeng SR; Lou YC; Pai MT; Jain ML; Cheng JW
J Biomol NMR; 2000 Apr; 16(4):303-12. PubMed ID: 10826882
[TBL] [Abstract][Full Text] [Related]
30. Tec homology (TH) adjacent to the PH domain.
Vihinen M; Nilsson L; Smith CI
FEBS Lett; 1994 Aug; 350(2-3):263-5. PubMed ID: 8070576
[TBL] [Abstract][Full Text] [Related]
31. The genomic structure of human BTK, the defective gene in X-linked agammaglobulinemia.
Rohrer J; Parolini O; Belmont JW; Conley ME; Parolino O [corrected to Parolini O]
Immunogenetics; 1994; 40(5):319-24. PubMed ID: 7927535
[TBL] [Abstract][Full Text] [Related]
32. Structural basis for pleckstrin homology domain mutations in X-linked agammaglobulinemia.
Vihinen M; Zvelebil MJ; Zhu Q; Brooimans RA; Ochs HD; Zegers BJ; Nilsson L; Waterfield MD; Smith CI
Biochemistry; 1995 Feb; 34(5):1475-81. PubMed ID: 7849006
[TBL] [Abstract][Full Text] [Related]
33. Genomic organization of the Btk gene and exon scanning for mutations in patients with X-linked agammaglobulinemia.
Hagemann TL; Chen Y; Rosen FS; Kwan SP
Hum Mol Genet; 1994 Oct; 3(10):1743-9. PubMed ID: 7880320
[TBL] [Abstract][Full Text] [Related]
34. Identification of nine novel mutations in the Bruton's tyrosine kinase gene in X-linked agammaglobulinaemia patients.
Orlandi P; Ritis K; Moschese V; Angelini F; Arvanitidis K; Speletas M; Sideras P; Plebani A; Rossi P
Hum Mutat; 2000 Jan; 15(1):117. PubMed ID: 10612838
[TBL] [Abstract][Full Text] [Related]
35. Bruton's tyrosine kinase: cell biology, sequence conservation, mutation spectrum, siRNA modifications, and expression profiling.
Lindvall JM; Blomberg KE; Väliaho J; Vargas L; Heinonen JE; Berglöf A; Mohamed AJ; Nore BF; Vihinen M; Smith CI
Immunol Rev; 2005 Feb; 203():200-15. PubMed ID: 15661031
[TBL] [Abstract][Full Text] [Related]
36. BTKbase, mutation database for X-linked agammaglobulinemia (XLA).
Vihinen M; Brandau O; Brandén LJ; Kwan SP; Lappalainen I; Lester T; Noordzij JG; Ochs HD; Ollila J; Pienaar SM; Riikonen P; Saha BK; Smith CI
Nucleic Acids Res; 1998 Jan; 26(1):242-7. PubMed ID: 9399844
[TBL] [Abstract][Full Text] [Related]
37. Structural basis of SH2 domain mutations in X-linked agammaglobulinemia.
Vihinen M; Nilsson L; Smith CI
Biochem Biophys Res Commun; 1994 Dec; 205(2):1270-7. PubMed ID: 7528500
[TBL] [Abstract][Full Text] [Related]
38. Regulation of nucleocytoplasmic shuttling of Bruton's tyrosine kinase (Btk) through a novel SH3-dependent interaction with ankyrin repeat domain 54 (ANKRD54).
Gustafsson MO; Hussain A; Mohammad DK; Mohamed AJ; Nguyen V; Metalnikov P; Colwill K; Pawson T; Smith CI; Nore BF
Mol Cell Biol; 2012 Jul; 32(13):2440-53. PubMed ID: 22527282
[TBL] [Abstract][Full Text] [Related]
39. Genomic organization and structure of Bruton agammaglobulinemia tyrosine kinase: localization of mutations associated with varied clinical presentations and course in X chromosome-linked agammaglobulinemia.
Ohta Y; Haire RN; Litman RT; Fu SM; Nelson RP; Kratz J; Kornfeld SJ; de la Morena M; Good RA; Litman GW
Proc Natl Acad Sci U S A; 1994 Sep; 91(19):9062-6. PubMed ID: 8090769
[TBL] [Abstract][Full Text] [Related]
40. Solution structure of the SH3 domain from Bruton's tyrosine kinase.
Hansson H; Mattsson PT; Allard P; Haapaniemi P; Vihinen M; Smith CI; Hard T
Biochemistry; 1998 Mar; 37(9):2912-24. PubMed ID: 9485443
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
